Miskolc, Hungary Clinical Trials

A listing of Miskolc, Hungary clinical trials actively recruiting patients volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 75 clinical trials
International Cooperative Treatment Protocol for Children and Adolescents With Lymphoblastic Lymphoma

Primary objectives: Randomization R1, all patients eligible: To examine, whether the cumulative incidence of relapses with involvement of the CNS (CNS relapse, pCICR) can be decreased by a modified induction therapy including dexamethasone (experimental arm) instead of prednisone (standard arm) Randomization R2, only patients with high risk LBL eligible: to …

Department of pediatric hematology and oncology, Children s University Hospital
 (45.7 away) Contact site
  • 0 views
  • 19 Jun, 2021
  • +223 other locations
Study to Evaluate the Efficacy (Effect on Disease) and Safety of Finerenone on Morbidity (Events Indicating Disease Worsening) & Mortality (Death Rate) in Participants With Heart Failure and Left Ventricular Ejection Fraction (Proportion of Blood Expelled Per Heart Stroke) Greater or Equal to 40%

The purpose of this study is to evaluate the effect of finerenone compared to placebo (a tablet without active substance) in the reduction of cardiovascular death (generally meaning death due to disease of the heart or blood vessels) and total Heart Failure (HF) events, including HF hospitalization and urgent visits …

natriuretic peptide
b-type natriuretic peptide
stroke
ejection fraction
heart failure
Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz
 (1.4 away) Contact site
  • 0 views
  • 01 Aug, 2021
  • +778 other locations
TO ASSESS THE EFFICACY AND SAFETY OF PF-06650833 PF-06651600 AND TOFACITINIB ALONE AND IN COMBINATION IN PARTICIPANTS WITH ACTIVE RHEUMATOID ARTHRITIS WITH AN INADEQUATE RESPONSE TO METHOTREXATE

Dual objectives of increased efficacy compared to currently available SoC RA drugs and maintaining a favourable benefit - risk relationship.

rheumatism
methotrexate
tofacitinib
erythrocyte sedimentation
high sensitivity
Huniko Kereskedelmi s Eg szs g gyi Szolg ltat Kft.
 (0.3 away) Contact site
  • 17 views
  • 03 Aug, 2021
  • +180 other locations
Zephyrus II: Efficacy and Safety Study of Pamrevlumab in Participants With Idiopathic Pulmonary Fibrosis (IPF)

This is a Phase 3 trial to evaluate the efficacy and safety of 30 mg/kg intravenous (IV) infusions of pamrevlumab administered every 3 weeks as compared to placebo in participants with Idiopathic Pulmonary Fibrosis (IPF). There is a 48-week randomized treatment phase followed by an optional, open-label extension phase.

idiopathic pulmonary fibrosis
carbon monoxide
diffusion capacity of the lung for carbon monoxide
pirfenidone
pamrevlumab
Miskolci Semmelweis Ign c Health Centre and Educational Clinic Nonprofit Ltd.
 (0.8 away) Contact site
  • 0 views
  • 02 Aug, 2021
  • +118 other locations
A Long-term Extension Study of Mirikizumab (LY3074828) in Participants With Crohn's Disease

The reason for this study is to determine the long-term efficacy and safety of the study drug mirikizumab in participants with Crohn's disease.

crohn's disease
Endomedix Diagnosztikai Kozpont
 (1.1 away) Contact site
  • 22 views
  • 24 Jul, 2021
  • +301 other locations
A Study of LY3462817 in Participants With Rheumatoid Arthritis

The reason for this study is to see if the study drug LY3462817 is safe and effective in participants with moderately to severely active rheumatoid arthritis (RA).

rheumatoid factor
antirheumatics
DMARD
rheumatism
biologic disease-modifying antirheumatic drug
CRU Hungary Kft.
 (0.8 away) Contact site
  • 0 views
  • 21 Jul, 2021
  • +35 other locations
Study to Assess PT010 in Adult and Adolescent Participants With Inadequately Controlled Asthma (KALOS)

This is a variable length study to evaluate the efficacy and safety of budesonide/glycopyrronium/formoterol inhaler in adults and adolescents with severe asthma inadequately controlled with standard of care.

Research Site
 (1.4 away) Contact site
  • 0 views
  • 26 Jul, 2021
  • +339 other locations
A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Crohn's Disease

The purpose of this study is to evaluate the efficacy of ustekinumab dosing in inducing clinical remission (Global) and in maintaining clinical remission (US); to evaluate the safety profile and ustekinumab exposure (pharmacokinetics [PK]) in pediatric participants with moderately to severely active Crohn's disease.

fistulising crohn's disease
ileitis
enteral nutrition
ustekinumab
pediatric onset crohn's disease
Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz
 (1.4 away) Contact site
  • 0 views
  • 16 Jul, 2021
  • +55 other locations
A Study of Ustekinumab in Pediatric Participants With Moderately to Severely Active Ulcerative Colitis (UC)

The purpose of this study is to evaluate: a) the efficacy of ustekinumab dosing in inducing clinical remission, b) safety profile of ustekinumab, and c) ustekinumab exposure (pharmacokinetics [PK]) in pediatric participants with moderately to severely active UC.

endoscopy
remission
Borsod-Abauj-Zemplen Megyei Korhaz es Egyetemi Oktato Korhaz
 (1.4 away) Contact site
  • 0 views
  • 18 Jul, 2021
  • +56 other locations
Zibotentan and Dapagliflozin for the Treatment of CKD (ZENITH-CKD Trial)

The purpose of the study is to assess efficacy, safety and tolerability of treatment with zibotentan and dapagliflozin in combination and alone, compared with placebo in participants with chronic kidney disease (CKD) with estimated glomerular filtration rate (eGFR) between 20 and 60 mL/min/1.73^2.

Research Site
 (1.4 away) Contact site
  • 0 views
  • 13 Jul, 2021
  • +149 other locations